Literature DB >> 11275371

Key peptide processing enzymes are expressed by breast cancer cells.

J Du1, B P Keegan, W G North.   

Abstract

The expression of the three key peptide processing enzyme families, represented by CPE, PAM, and PC1/3 plus PC2, were examined in MCF-7 and ZR-75-1 breast cancer cell lines. Both of these cell lines express vasopressin receptors as well as the vasopressin gene, but the processing of vasopressin gene-related proteins appears to be limited. Products of the expected size for, CPE, PAM and PC1/PC3 could be amplified by reverse transcription-polymerase chain reaction (RT-PCR) from both cell lines. Cloning and sequencing of these RT-PCR products revealed that each enzyme mRNA had a structure identical to that published for the human form of the respective enzyme. Western analysis provided evidence that mRNAs for these enzymes are translated into proteins. Alternatively, PC2 mRNA was identified to be present in MCF-7 cells both by RT-PCR and Western blot analysis, but could not be demonstrated for ZR-75-1 cells. Our findings suggest that the key processing enzymes needed to generate active vasopressin and other neuropeptide growth factors are present in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275371     DOI: 10.1016/s0304-3835(01)00409-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

Review 1.  New roles of carboxypeptidase E in endocrine and neural function and cancer.

Authors:  Niamh X Cawley; William C Wetsel; Saravana R K Murthy; Joshua J Park; Karel Pacak; Y Peng Loh
Journal:  Endocr Rev       Date:  2012-03-07       Impact factor: 19.871

2.  Carboxypeptidase E: a negative regulator of the canonical Wnt signaling pathway.

Authors:  N Skalka; M Caspi; E Caspi; Y P Loh; R Rosin-Arbesfeld
Journal:  Oncogene       Date:  2012-07-23       Impact factor: 9.867

3.  Overexpression of CPE-ΔN predicts poor prognosis in colorectal cancer patients.

Authors:  Kun Zhou; Hongyan Liang; Yang Liu; Chun Yang; Peijia Liu; Xiaofeng Jiang
Journal:  Tumour Biol       Date:  2013-07-14

4.  Carboxypeptidase E: elevated expression correlated with tumor growth and metastasis in pheochromocytomas and other cancers.

Authors:  Saravana R K Murthy; Karel Pacak; Y Peng Loh
Journal:  Cell Mol Neurobiol       Date:  2010-11       Impact factor: 5.046

Review 5.  Carboxypeptidase E and its splice variants: Key regulators of growth and metastasis in multiple cancer types.

Authors:  Sangeetha Hareendran; Xuyu Yang; Vinay Kumar Sharma; Y Peng Loh
Journal:  Cancer Lett       Date:  2022-08-18       Impact factor: 9.756

Review 6.  Role of subtilisin-like convertases in cadherin processing or the conundrum to stall cadherin function by convertase inhibitors in cancer therapy.

Authors:  E J Müller; R Caldelari; H Posthaus
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

7.  Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis.

Authors:  Mark E Reeves; Scott W Baldwin; Melissa L Baldwin; Shin-Tai Chen; Jeremy M Moretz; Robert J Aragon; Xinmin Li; Donna D Strong; Subburaman Mohan; Yousef G Amaar
Journal:  BMC Cancer       Date:  2010-10-18       Impact factor: 4.430

8.  Membrane-bound carboxypeptidase E facilitates the entry of eosinophil cationic protein into neuroendocrine cells.

Authors:  Chia-Mao Wu; Hao-Teng Chang; Margaret Dah-Tsyr Chang
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

Review 9.  Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.

Authors:  Abdel-Majid Khatib; Géraldine Siegfried; Michel Chrétien; Peter Metrakos; Nabil G Seidah
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

10.  Carboxypeptidase E is a novel modulator of RANKL-induced osteoclast differentiation.

Authors:  Hyun-Ju Kim; JungMin Hong; Hye-Jin Yoon; Young-Ran Yoon; Shin-Yoon Kim
Journal:  Mol Cells       Date:  2014-09-15       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.